PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma

Conditions:   Classical Hodgkin Lymphoma;   Lymphocyte-Depleted Classical Hodgkin Lymphoma;   Lymphocyte-Rich Classical Hodgkin Lymphoma;   Mixed Cellularity Classical Hodgkin Lymphoma;   Nodular Sclerosis Classical Hodgkin Lymphoma
Interventions:   Procedure: Computed Tomography;   Drug: Dacarbazine;   Drug: Doxorubicin Hydrochloride;   Radiation: Fludeoxyglucose F-18;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Procedure: Positron Emission Tomography;   Drug: Vinblastine Sulfate
Sponsors:   Northwestern University;   National Cancer Institute (NCI)
Not yet recruiting - verified July 2017

http://ift.tt/2vIBxU9